151433-82-8Relevant articles and documents
Design of [R-(Z)]-(+)-α-(methoxyimino)-1-azabicyclo[2.2.2]octane-3- acetonitrile (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere
Bromidge, Steven M.,Brown, Frank,Cassidy, Frederick,Clark, Michael S. G.,Dabbs, Steven,Hadley, Michael S.,Hawkins, Julie,Loudon, Julia M.,Naylor, Christopher B.,Orlek, Barry S.,Riley, Graham J.
, p. 4265 - 4280 (1997)
Loss of cholinergic function is believed to be implicated in the cognitive decline associated with senile dementia of the Alzheimer type (SDAT). The disease is characterized by progressive loss of muscarinic receptors located on nerve terminals while postsynaptic muscarinic M1 receptors appear to remain largely intact. Muscarinic agonists acting directly on postsynaptic receptors offer the prospect of countering the cholinergic deficit in SDAT. This study describes a novel series of azabicyclic muscarinic agonists, which incorporate an oxime ether or modified oxime ether group as an ester bioisotere. Modification of the oxime ether function by the introduction of electron withdrawing groups led to the finding that the (Z)-N-methoxy imidoyl nitrile group serves as a stable methyl ester bioisostere. This culminated in the discovery of the quinuclidinyl N-methoxy imidoyl nitrile (R)-(+)-(Z)-5g which is a functionally selective muscarinic M1 partial agonist currently in phase III clinical trials for the treatment of SDAT. The selective profile of R-(+)- (Z)-5g can be rationalized in terms of the relative affinity of the compound at muscarinic receptor subtypes, the degree of agonist efficacy, and brain penetrancy.
AZABICYLO OXIME COMPOUNDS
-
, (2008/06/13)
A compound of formula (I) or a pharmaceutically acceptable salt thereof: STR1 wherein R 1 represents STR2 in which each of p and q independently represents an integer of 2 to 4, r represents an integer of 2 to 4, s represents 1 or 2 and t represents 0 or 1; R 2 is a group OR 4, where R 4 is C 1-4 alkyl, C. sub.2-4 alkenyl, C 2-4 alkynyl, a group OCOR 5 where R 5 is hydrogen or R 4, or a group NHR 6 or NR 7 R 8 where R 6, R 7 and R 8 are independently C 1-2 alkyl; and R 3 is chloro, fluoro, bromo, cyclopropyl, C 1-3 alkyl substituted by one, two or three halogen atoms, or R 3 is a group (CH. sub.2) n R 9 where R 9 is--CN,--OH,--OCH 3,--SH,--SCH 3,--C CH or--CH=CH 2 and n is O or 1, with the proviso that when n is 0, R 9 is not--OH or--SH.
